{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T17:09:55Z","timestamp":1771607395081,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.abd.2025.501261","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:42:27Z","timestamp":1769164947000},"page":"501261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment response in chronic urticaria: analysis of clinical and laboratory predictors"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9598-9709","authenticated-orcid":false,"given":"Joice Trigo da","family":"Fonseca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanemile Pacheco de","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila Vieira Borges Trancoso","family":"Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Carlisson Santos de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janinne Souza de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vit\u00f3ria Rani","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9gis de Albuquerque","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2025.501261_bib0005","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.abd.2025.501261_bib0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13601-015-0072-9","article-title":"ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria","volume":"5","author":"Weller","year":"2015","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.abd.2025.501261_bib0015","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/jdv.15350","article-title":"Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients","volume":"33","author":"Marzano","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2025.501261_bib0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-022-00389-z","article-title":"Urticaria","volume":"8","author":"Kolkhir","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.abd.2025.501261_bib0025","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1111\/all.14757","article-title":"Predictors of treatment response in chronic spontaneous urticaria","volume":"76","author":"Fok","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.abd.2025.501261_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1684\/ejd.2024.4600","article-title":"Biomarkers to predict therapeutic response in chronic spontaneous urticaria: a review","volume":"34","author":"Gimenez-Arnau","year":"2024","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.abd.2025.501261_bib0035","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jaip.2018.03.007","article-title":"How to approach chronic inducible urticaria","volume":"6","author":"Maurer","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.abd.2025.501261_bib0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jaip.2019.08.025","article-title":"Eosinopenia, in chronic spontaneous urticaria, is associated with high disease activity, autoimmunity, and poor response to treatment","volume":"8","author":"Kolkhir","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.abd.2025.501261_bib0045","doi-asserted-by":"crossref","first-page":"516","DOI":"10.5114\/ada.2017.71422","article-title":"The effect of omalizumab treatment on IgE and other immunoglobulin levels in patients with chronic spontaneous urticaria and its association with treatment response","volume":"35","author":"\u00c7ilda\u01e7","year":"2018","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.abd.2025.501261_bib0050","first-page":"209","article-title":"Ferramentas para avalia\u00e7\u00e3o e acompanhamento da urtic\u00e1ria cr\u00f4nica","volume":"2","author":"Valle","year":"2018","journal-title":"Arq Asma Alerg Imunol"},{"key":"10.1016\/j.abd.2025.501261_bib0055","first-page":"170","article-title":"2022 Brazilian guidelines for hereditary angioedema - Part 2: therapy","volume":"6","author":"Campos","year":"2022","journal-title":"Arq Asma Alerg Imunol"},{"key":"10.1016\/j.abd.2025.501261_bib0060","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.jaci.2017.04.052","article-title":"Relationship between EASI and SCORAD severity assessments for atopic dermatitis","volume":"140","author":"Chopra","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.abd.2025.501261_bib0065","doi-asserted-by":"crossref","first-page":"208","DOI":"10.23822\/EurAnnACI.1764-1489.12","article-title":"The link between chronic spontaneous urticaria and metabolic syndrome","volume":"49","author":"Vena","year":"2017","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.abd.2025.501261_bib0070","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/ced.13368","article-title":"Overweight and obesity may play a role in the pathogenesis of chronic spontaneous urticaria","volume":"43","author":"Zbiciak-Nylec","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2025.501261_bib0075","first-page":"168a-b","article-title":"Clinical Inquiry. What is the prognosis for patients with chronic urticaria?","volume":"60","author":"Engstrom","year":"2011","journal-title":"J Fam Pract"},{"key":"10.1016\/j.abd.2025.501261_bib0080","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1398-9995.2004.00473.x","article-title":"Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients","volume":"59","author":"Toubi","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.abd.2025.501261_bib0085","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jaci.2024.11.036","article-title":"Mortality in adult patients with chronic spontaneous urticaria: a real-world cohort study","volume":"155","author":"Kolkhir","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.abd.2025.501261_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2023.100843","article-title":"Disease burden and predictors associated with non-response to antihistamine-based therapy in chronic spontaneous urticaria","volume":"16","author":"Soong","year":"2023","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.abd.2025.501261_bib0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13601-019-0278-3","article-title":"Psychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis","volume":"9","author":"Konstantinou","year":"2019","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.abd.2025.501261_bib0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13223-020-00496-0","article-title":"Refractory chronic urticaria in adults: clinical characterization and predictors of severity","volume":"16","author":"Alen Coutinho","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.abd.2025.501261_bib0105","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.990","article-title":"The effect of substance P and its common in vivo-formed metabolites on MRGPRX2 and human mast cell activation","volume":"10","author":"Hsin","year":"2022","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.abd.2025.501261_bib0110","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/all.13352","article-title":"C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria","volume":"73","author":"Kolkhir","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.abd.2025.501261_bib0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5415\/apallergy.2013.3.2.100","article-title":"Correlation between plasma D-dimer levels and the severity of patients with chronic urticaria","volume":"3","author":"Triwongwaranat","year":"2013","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.abd.2025.501261_bib0120","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/ced.12413","article-title":"Severity of acute and chronic urticaria correlates with D-dimer level, but not C-reactive protein or total IgE","volume":"39","author":"Baek","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2025.501261_bib0125","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jaci.2020.03.005","article-title":"The role of eosinophils in chronic spontaneous urticaria","volume":"145","author":"Altrichter","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.abd.2025.501261_bib0130","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.jaip.2023.06.026","article-title":"The crucial role of IgE as a predictor of treatment response to omalizumab in chronic spontaneous urticaria","volume":"11","author":"Maurer","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.abd.2025.501261_bib0135","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4168\/aair.2021.13.2.206","article-title":"Total IgE as a marker for chronic spontaneous urticaria","volume":"13","author":"Altrichter","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.abd.2025.501261_bib0140","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.jaip.2023.05.033","article-title":"Association between serum total IgE levels and clinical response to omalizumab for chronic spontaneous urticaria: a systematic review and meta-analysis","volume":"11","author":"Chuang","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.abd.2025.501261_bib0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jdermsci.2013.08.011","article-title":"Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis","volume":"73","author":"Metz","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.abd.2025.501261_bib0150","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2500\/aap.2013.34.3694","article-title":"Retrospective analysis of the efficacy of omalizumab in chronic refractory urticaria","volume":"34","author":"Viswanathan","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.abd.2025.501261_bib0155","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.3390\/ijms24087491","article-title":"Thyroid autoimmunity in CSU: a potential marker of omalizumab response?","volume":"24","author":"Asero","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.abd.2025.501261_bib0160","doi-asserted-by":"crossref","first-page":"545","DOI":"10.4168\/aair.2021.13.4.545","article-title":"Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria","volume":"13","author":"Kolkhir","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.abd.2025.501261_bib0165","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/all.13182","article-title":"Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: a systematic review","volume":"72","author":"Kolkhir","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.abd.2025.501261_bib0170","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/all.14033","article-title":"Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU","volume":"75","author":"Erta\u015f","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.abd.2025.501261_bib0175","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2024.1451296","article-title":"IgE as a predictor to omalizumab response in patients with chronic spontaneous urticaria","volume":"5","author":"Ensina","year":"2025","journal-title":"Front Allergy"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036505962500203X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036505962500203X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:19:03Z","timestamp":1771604343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036505962500203X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S036505962500203X"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2025.501261","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment response in chronic urticaria: analysis of clinical and laboratory predictors","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2025.501261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedade Brasileira de Dermatologia.","name":"copyright","label":"Copyright"}],"article-number":"501261"}}